ICHR trades 44.6% above Wall Street's consensus target of $54.60.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ICHR achieves its forward estimates and maintains a stable P/E multiple of 71.5x. This scenario reflects the blended consensus of 14 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Ichor Holdings, Ltd. (ICHR) has a Wall Street consensus price target of $54.60, based on estimates from 14 covering analysts. With the stock currently trading at $98.61, this represents a potential downside of -44.6%. The company has a market capitalization of $3.43B.
Analyst price targets range from a low of $36.00 to a high of $76.00, representing a 73% spread in expectations. The median target of $53.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 12 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ICHR trades at a trailing P/E of -64.0x and forward P/E of 71.5x. Analysts expect EPS to grow +194.1% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MKSIMKS Inc. | $27.4B | $406.37 | $322.00 | -20.8% | Buy | 34.7x | 29 |
UCTTUltra Clean Holdings, Inc. | $5.5B | $121.28 | $103.75 | -14.5% | Buy | 46.8x | 12 |
CAMTCamtek Ltd. | $8.9B | $195.16 | $178.56 | -8.5% | Buy | 55.7x | 13 |
AZTAAzenta, Inc. | $1.1B | $23.31 | $44.50 | +90.9% | Buy | 52.0x | 12 |
ENTGEntegris, Inc. | $27.2B | $178.77 | $152.71 | -14.6% | Buy | 49.1x | 26 |
ONTOOnto Innovation Inc. | $16.6B | $333.76 | $338.88 | +1.5% | Buy | 46.5x | 11 |
ACMRACM Research, Inc. | $7.3B | $109.87 | $100.00 | -9.0% | Buy | 55.2x | 10 |
NVMINova Ltd. | $18.3B | $575.31 | $566.80 | -1.5% | Buy | 54.9x | 13 |
AMATApplied Materials, Inc. | $490.0B | $617.11 | $533.65 | -13.5% | Buy | 50.5x | 53 |
LRCXLam Research Corporation | $485.8B | $389.04 | $349.22 | -10.2% | Buy | 68.5x | 50 |
Quick answers to the most common questions about buying ICHR stock.
ICHR's consensus price target is $54.6, -44.6% below the current price of $98.61. The 14 analysts tracking ICHR see downside risk at present valuations.
ICHR has a consensus rating of "Buy" based on 14 Wall Street analysts. The rating breakdown is predominantly bullish, with 12 Buy/Strong Buy ratings. The consensus 12-month price target of $54.6 implies -44.6% downside from current levels.
At a forward P/E of 71.5291x, ICHR trades at a premium valuation. The consensus price target of $54.6 (-44.6% downside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $76 for ICHR, while the most conservative target is $36. The consensus of $54.6 represents the median expectation. These targets typically reflect 12-month expectations.
ICHR is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 12 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ICHR stock forecast based on 14 Wall Street analysts shows a consensus price target of $54.6, with estimates ranging from $36 (bear case) to $76 (bull case). The median consensus rating is "Buy".
ICHR trades at a forward P/E ratio of 71.5x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on ICHR, with 0 Sell ratings and a price target of $54.6 (-44.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ICHR analyst price targets range from $36 to $76, a 73% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $54.6 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.